Overview

  • Product nameAnti-PARC antibody
    See all PARC primary antibodies
  • Description
    Rabbit polyclonal to PARC
  • Tested applicationsSuitable for: WB, IP, ELISAmore details
  • Species reactivity
    Reacts with: Mouse, Human
  • Immunogen

    Synthetic peptide: FFFGDEEEDEDEAYD conjugated to KLH, corresponding to C terminal amino acids 2503 - 2517 of Human PARC

  • Positive control
    • Most cell lines expressing PARC can be used as a positive control. HeLa and NHI 3T3 cell lysates.

Properties

  • FormLiquid
  • Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
  • Storage bufferPreservative: 0.01% Sodium Azide
    Constituents: Whole serum
  • PurityWhole antiserum
  • Purification notesab34847 is monospecific antiserum processed by delipidation and defibrination followed by sterile filtration.
  • ClonalityPolyclonal
  • IsotypeIgG
  • Research areas

Applications

Our Abpromise guarantee covers the use of ab34847 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500 - 1/1000. Detects a band of approximately 281 kDa (predicted molecular weight: 281 kDa).
IP Use at an assay dependent dilution.
ELISA 1/2000 - 1/10000.

Target

  • FunctionCytoplasmic anchor protein in p53-associated protein complex. Regulates the subcellular localization of p53 and subsequent function. Seems to be part of an atypical cullin-RING-based E3 ubiquitin-protein ligase complex. In vitro, complexes of CUL9/PARC with either CUL7 or TP53 contain E3 ubiquitin-protein ligase activity.
  • Tissue specificityUbiquitously expressed in all tissues with highest expression in testis brain and kidney.
  • Sequence similaritiesBelongs to the cullin family.
    Contains 1 DOC domain.
    Contains 1 IBR-type zinc finger.
    Contains 2 RING-type zinc fingers.
  • DomainThe IBR domain is required for interaction with UBCH7 and UBCH8.
  • Post-translational
    modifications
    In vitro, self-ubiquitination in the presence of E1, E2 and ubiquitin.
    Neddylated.
  • Cellular localizationCytoplasm.
  • Information by UniProt
  • Database links
  • Alternative names
    • CUL-9 antibody
    • Cul9 antibody
    • CUL9_HUMAN antibody
    • Cullin-9 antibody
    • DKFZp686G1042 antibody
    • DKFZp686P2024 antibody
    • H7AP1 antibody
    • KIAA0708 antibody
    • OTTHUMP00000039816 antibody
    • p53 associated parkin like cytoplasmic protein antibody
    • p53-associated parkin-like cytoplasmic protein antibody
    • PARC antibody
    • parkin-like cytoplasmic p53 binding protein antibody
    • RP3 330M21.2 antibody
    • UbcH 7 associated protein 1 antibody
    • UbcH7 associated protein 1 antibody
    • UbcH7-associated protein 1 antibody
    see all

References for Anti-PARC antibody (ab34847)

ab34847 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab34847.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"